Cramer's Morning Take: Microsoft & Viking Therapeutics 3/26/24
26/03/2024
0:00
3:37
Jim and Jeff discuss the analyst price target increase for Microsoft. They also talk about the weight loss drug opportunity for Viking Therapeutics. Become a CNBC Investing Club member to go behind the scenes with Jim Cramer and Jeff Marks as they talk candidly about the market’s biggest headlines. Signup here: cnbc.com/morningtake
Mais episódios de "Squawk on the Street"
Não percas um episódio de “Squawk on the Street” e subscrevê-lo na aplicação GetPodcast.